VBI Vaccines (TSX:VBV) Cash Flow for Dividends : C$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is VBI Vaccines Cash Flow for Dividends?

VBI Vaccines's cash flow for dividends for the three months ended in Dec. 2023 was C$0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

VBI Vaccines Cash Flow for Dividends Historical Data

The historical data trend for VBI Vaccines's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VBI Vaccines Cash Flow for Dividends Chart

VBI Vaccines Annual Data

Trend

Mar14

Mar15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

VBI Vaccines Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-	-	-

VBI Vaccines Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

VBI Vaccines Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of VBI Vaccines's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

VBI Vaccines (TSX:VBV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VBI Vaccines Inc (TSX:VBV) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

VBIV:USA LO9A:Germany LO9A:Germany

Address

160 Second Street, Floor 3, Cambridge, MA, USA, 02142

Website

https://www.vbivaccines.com

VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.

VBI Vaccines (TSX:VBV) Headlines

No Headlines